ITS is the premier provider of infusible biologics to effectively address desensitization of highly HLA-sensitized patients and ABO
incompatible recipients as well as providing treatment for antibody-mediated rejection and chronic antibody-mediated rejection.
ITS provides the full spectrum of biologic treatments required to achieve transplantation successfully and combat rejection episodes.
We are fully equipped to support solid organ transplant centers by securing authorization, administering treatment and reviewing blood
draws before and after treatment and sending to transplant centers for HLA testing, as needed.